BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.
-
Upload
willa-hicks -
Category
Documents
-
view
216 -
download
2
Transcript of BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.
![Page 1: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/1.jpg)
BIOS E-162B Undergraduate Review:
Neuropathophysiology II and III
October 4, 2010
![Page 2: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/2.jpg)
HOT!
HOT!
Afferent pathway (sensory)
![Page 3: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/3.jpg)
The CNS: interneurons, convergence, and divergence
HOT!
HOT!
Via association cortex
![Page 4: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/4.jpg)
Efferent Pathway (motor)MOVE!
SLOW AND STEADY!
REFINE!MOVE!
![Page 5: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/5.jpg)
How movement occurs:The neruomuscular junction
1. Action potential reaches motor neuron terminal 2. Ca2+ enters
3. Vessicles of acetylcholine bind to synaptic cleft
4. Acetylcholine binds to nicotinic receptors on motor end plate
5. Signal to muscle to contract
6. Acetylcholinesterase breaks down acetylcholine, reuptake of acetylcholine into presynaptic neuron
![Page 6: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/6.jpg)
Drugs/Toxins
![Page 7: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/7.jpg)
Curare
• Acts as an antagonist for Ach binding
![Page 8: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/8.jpg)
Botulinum toxin
• Cleaves docking proteins off of the Ach-containing vessicles
![Page 9: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/9.jpg)
Organophosphates
• Inhibit acetylcholinesterase
![Page 10: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/10.jpg)
Strychnine
• Antagonist of the inhibitory neurotransmitter glycine
![Page 11: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/11.jpg)
Tetanus
• Inhibits release of inhibitory transmitter GABA from pre-synaptic nerve terminals in CNS
![Page 12: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/12.jpg)
Diseases
Genetics Injury/ Toxicity
Infection Immune
Myathenia gravis
Parkinson’s
MS
ALS
Guillain-Barre
![Page 13: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/13.jpg)
Myathenia gravis
• B-cells make antibodies that bind to and block Ach nicotinic receptors
• Progressive muscle weakness, usually first at eyes
• Respiratory failure most life-threatening
• Treatment: mechanical ventilation, neostigmine, thymectomy
![Page 14: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/14.jpg)
Parkinson’s Disease
• Loss of dopamine-producing neurons in a region of the basal ganglia
• Side effect of treatment drugs: schizoid behavior
![Page 15: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/15.jpg)
Multiple sclerosis
• Demyelinization of CNS neurons
• Initially present with blurred or double vision
• Muscle weakness, loss of coordination/balance, spasticity, fatigue, paresthesias
• Tysabri appears to be an effective treatment, but with “black box” warning
![Page 16: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/16.jpg)
Amotrophic lateral sclerosis (ALS)
• Loss of upper and lower motor neurons
• Muscle weakness, cramping, atrophy• Respiratory failure, choking• “Charcot ALS” (lower motor neurons first)
vs. “bulbar onset ALS” (upper motor neurons first)
• Riluzole slows progression of ALS, Baclofen relieves muscle spasticity
![Page 17: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/17.jpg)
Guillain-Barre syndrome
• Demyelination of peripheral nerves
• Weakness of respiratory muscles, paresthesia
• Most people recover within one year
![Page 18: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/18.jpg)
Other CNS injuries
![Page 19: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/19.jpg)
Traumatic brain injury
• Damage to nerve axons, leads to loss of axon terminals
• Excitotoxicity and oxidative stress from release of neurotransmitters from damaged cells (esp glutamate)
• Hemorrhages, bruising, pressure from swelling
• Permanent damage, usually
![Page 20: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/20.jpg)
Spinal cord injury
• From trauma, but also from release of neurotrasmitters (esp glutamate)
• Damage depends on site of injury:
![Page 21: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/21.jpg)
SCI II
• Consequences– Loss of temperature control– Brown-Sequard’s syndrome– Pressure wounds– Autonomic dysreflexia
![Page 22: BIOS E-162B Undergraduate Review: Neuropathophysiology II and III October 4, 2010.](https://reader030.fdocuments.us/reader030/viewer/2022032612/56649eeb5503460f94bfcc65/html5/thumbnails/22.jpg)
Stroke
• Protection– Circle of Willis– Myogenic autoregulation
• Ischemic (~85% of strokes)– Portion of blood flow to brain is blocked (by
thrombus or embolus)– Ischemic penumbra
• Hemorrhagic (~15% of strokes)– Blood vessel ruptures